Spruce Street Capital LP
Q3 2026 13F-HR Holdings
Net value change ($000)
+119,303
(23.4%)
New positions
9
Sold out positions
0
Turnover %
16.3%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2026
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ENTXW | 32,631 | NEW |
| ZLAB | 22,147 | 417.6% |
| OBSIDIAN THERAPEUTICS INC | 17,162 | NEW |
| SGMT | 13,832 | NEW |
| YARROW BIOSCIENCE INC | 13,678 | NEW |
| KORSANA BIOSCIENCES INC | 10,304 | NEW |
| ALKERMES PLC | 9,936 | 34.9% |
| KNSA | 9,786 | 16.7% |
| LBRX | 9,200 | 20.6% |
| ANRO | 7,096 | 19.9% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|